| Name |
CAS NO. |
Usage |
Chemical Structure |
| 4-Nitrophenyl, 2-[(furanylmethyl)sulfinyl]acetate |
123855-55-0 |
Lafutidine intermediate |
![4-Nitrophenyl, 2-[(furanylmethyl)sulfinyl]acetate](/uploadfile_s/2009624163738288.gif) |
| N-{4-[4-(piperidinomethyl)pyridyl-2-oxy]-cis-2-butene} |
146447-26-9 |
Lafutidine intermediate |
![N-{4-[4-(piperidinomethyl)pyridyl-2-oxy]-cis-2-butene}](/uploadfile_s/2009624161330530.gif) |
| Lafutidine |
118288-08-7 |
Gastric ulcer and duodenal ulcer agent |
 |
| 5-{4-[2-(5-ethyl-2-Pyridyl)ethoxy]Benzyl}-2,4-Thiazolidinedione |
105390-47-4 |
Pioglitazone HCl intermediate |
![5-{4-[2-(5-ethyl-2-Pyridyl)ethoxy]Benzyl}-2,4-Thiazolidinedione](/uploadfile_s/200962416924174.gif) |
| 5-{4-[2-(5-ethyl-2-Pyridyl)ethoxy]Benzylidene}-2,4-Thiazolidinedione |
144809-28-9 |
Pioglitazone HCl intermediate |
![5-{4-[2-(5-ethyl-2-Pyridyl)ethoxy]Benzylidene}-2,4-Thiazolidinedione](/uploadfile_s/200962416714754.gif) |
| 5-{4-[2-(5-ethyl-2-Pyridyl)ethoxy]Benzyl}-2-imino-4-Thiazolidione |
105355-26-8 |
Pioglitazone HCl intermediate |
![5-{4-[2-(5-ethyl-2-Pyridyl)ethoxy]Benzyl}-2-imino-4-Thiazolidione](/uploadfile_s/200962416559637.gif) |
| 4-[2-(2-bromo-3-{4-[2-(5-ethyl-pyridin-2-yl)-ethoxy]-phenyl}-propionic acid methyl ester |
105355-25-7 |
Pioglitazone HCl intermediate |
![4-[2-(2-bromo-3-{4-[2-(5-ethyl-pyridin-2-yl)-ethoxy]-phenyl}-propionic acid methyl ester](/uploadfile_s/200962416425667.gif) |
| 5-ethyl-2-[2-(4-nitro-phenoxy)-ethyl]-pyridine |
85583-54-6 |
Pioglitazone HCl intermediate |
![5-ethyl-2-[2-(4-nitro-phenoxy)-ethyl]-pyridine](/uploadfile_s/2009624155516797.gif) |
| Pioglitazone HCl |
112529-15-4 |
Hypoglycemic agent |
 |
| L-Alaninol ( 2-Amino-1-propanol ) |
2749-11-3 |
Levofloxacin HCl intermediate |
 |
| Ethyl, 2,3,4,5-tetrafluoro benzoyl acetate |
94695-50-8 |
Levofloxacin HCl intermediate |
 |
| Levofloxacin hemihydrate |
100986-85-4 |
Antibiotics |
 |
| Levofloxacin HCl |
177325-13-2 |
Genito-urinary system infection; respiratory infection; gastrointestinal tract infection; typhoid; bone and joint infections; skin and soft tissue infections |
 |
| 4-Hydroxypiperidine |
5382-16-1 |
Nadifloxacin intermediate |
 |
| (¡À)-8,9-difluoro-5-methyl-6,7-dihydro-1-oxo-1H,5H-benzo[i,j] |
80076-47-7 |
Nadifloxacin intermediate |
![(¡À)-8,9-difluoro-5-methyl-6,7-dihydro-1-oxo-1H,5H-benzo[i,j]](/uploadfile_s/2009624152933689.gif) |
| Nadifloxacin |
124858-35-1 |
antibacterial agent |
 |
| 5,6-Dimethoxy-2-(piperidin-4-yl)methyl-indan-1-one HCl |
120013-39-0 |
Donepezil HCl intermediate |
 |
| 1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2-ylindenemethyl)-piperidine |
120014-07-5 |
Donepezil HCl intermediate |
 |
| 1-Benzyl-4-Piperidine carboxaldehyde |
22065-85-6 |
Donepezil HCl intermediate |
 |
| 5,6-dimethoxyindanone |
2107-69-9 |
Donepezil HCl intermediate |
 |
|